---
title: "Publications & Research"
description: "Academic publications, research papers, and essays"
---

<div style="margin: 2em 0;">

## ğŸ“ Medium Articles

<div style="background: #f8f9fa; padding: 1.5em; border-radius: 8px; margin: 1em 0;">

**Latest Essays on AI & Biotechnology**

Exploring the intersection of artificial intelligence, structural biology, and precision medicine.

**[ğŸ“– Read all articles on Medium â†’](https://medium.com/@sinclairhuang)**

### Featured: AlphaFold 3 Series

A comprehensive exploration of how AI is revolutionizing our understanding of life at the molecular level.

- ğŸ§¬ **Part VIII**: From Folding to Healing  
  *When AlphaFold 3 Starts Whispering Cures*  
  [Read on Medium â†’](https://medium.com/@sinclairhuang/from-folding-to-healing-when-ai-begins-to-suggest-treatments-f2f661b71af6)

</div>

</div>

---

## ğŸ“š Academic Publications

<div style="display: grid; gap: 1.5em; margin: 2em 0;">

<div style="background: #fff; border: 1px solid #e1e4e8; padding: 1.5em; border-radius: 8px;">

### Zenodo Research Repository

Comprehensive research datasets, preprints, and supplementary materials with DOI registration.

**[ğŸ”¬ View Research Outputs on Zenodo â†’](https://zenodo.org/users/sinclairhuang)**

</div>

<div style="background: #fff; border: 1px solid #e1e4e8; padding: 1.5em; border-radius: 8px;">

### SSRN Working Papers

**Policy-Conditioned Dynamic Capabilities and AI-Driven Valuation**

*Huang, Sinclair (2025)*  
SSRN Working Paper No. 5843722

Analyzing the impact of AI-driven methodologies on semiconductor firm valuation using GEE regression and Random Forest models across 95 global firms.

**[ğŸ“„ Read Full Paper â†’](https://ssrn.com/abstract=5843722)**

</div>

</div>

---

## ğŸ¯ Research Focus Areas

- **Computational Biology**: AlphaFold 3, protein structure prediction, molecular dynamics
- **AI in Drug Discovery**: Precision medicine, targeted therapeutics, molecular design
- **Semiconductor Industry**: AI-driven valuation models, competitive analysis (95 firms, 2020-2025)
- **Biotechnology**: Precision oncology, metabolic disease, regenerative medicine
- **Strategic Management**: Dynamic capabilities, R&D efficiency, competitive intelligence

---

## ğŸ¤ Collaboration & Contact

Interested in research collaboration or have questions about my work?

**ORCID**: [0009-0007-8173-5672](https://orcid.org/0009-0007-8173-5672)

*For research inquiries, please connect via ORCID or professional networks.*

